Ausdal Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35,271
| Closed | -$4.31M | – | 462 |
|
|
2023
Q3 | $4.31M | Buy |
+35,271
| New | +$4.31M | 0.59% | 33 |
|
|
2018
Q4 | – | Sell |
-2,043
| Closed | -$249K | – | 310 |
|
|
2018
Q3 | $249K | Buy |
2,043
+47
| +2% | +$5.73K | 0.07% | 316 |
|
|
2018
Q2 | $219K | Buy |
+1,996
| New | +$219K | 0.07% | 342 |
|
|
2018
Q1 | – | Sell |
-2,099
| Closed | -$224K | – | 374 |
|
|
2017
Q4 | $224K | Buy |
2,099
+29
| +1% | +$3.1K | 0.08% | 310 |
|
|
2017
Q3 | $230K | Buy |
2,070
+87
| +4% | +$9.67K | 0.09% | 286 |
|
|
2017
Q2 | $205K | Buy |
+1,983
| New | +$205K | 0.09% | 282 |
|
|
2017
Q1 | – | Sell |
-2,613
| Closed | -$231K | – | 292 |
|
|
2016
Q4 | $231K | Buy |
+2,613
| New | +$231K | 0.11% | 215 |
|
|
2016
Q1 | – | Sell |
-1,071
| Closed | -$121K | – | 586 |
|
|
2015
Q4 | $121K | Buy |
+1,071
| New | +$121K | 0.06% | 272 |
|